Global Fabry Disease Therapeutic Market Size, Status and Forecast 2022

October 2017 | 104 pages | ID: GB03E37D233PEN
QYResearch

Abstracts

This report studies the global Fabry Disease Therapeutic market, analyzes and researches the Fabry Disease Therapeutic development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Amicus therapeutics
• Shire
• Genzyme-Sanofi
• Protalix
• Sanofi-Aventis LLC
• Novartis Pharmaceuticals
• Pfizer
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Amgen Inc.
• Teva pharmaceutical Industries Ltd.
• Merc & Co.
• AbbVie Inc.
• Takeda Pharmaceutical Co. Ltd.
• Green Cross Corp.

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Fabry Disease Therapeutic can be split into

• Enzyme Replacement Therapy
• Alternative therapies

Market segment by Application, Fabry Disease Therapeutic can be split into

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Fabry Disease Therapeutic Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF FABRY DISEASE THERAPEUTIC

1.1 Fabry Disease Therapeutic Market Overview
  1.1.1 Fabry Disease Therapeutic Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Fabry Disease Therapeutic Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Fabry Disease Therapeutic Market by Type
  1.3.1 Enzyme Replacement Therapy
  1.3.2 Alternative therapies
1.4 Fabry Disease Therapeutic Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Other

2 GLOBAL FABRY DISEASE THERAPEUTIC COMPETITION ANALYSIS BY PLAYERS

2.1 Fabry Disease Therapeutic Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Amicus therapeutics
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Shire
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Genzyme-Sanofi
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Protalix
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Sanofi-Aventis LLC
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Novartis Pharmaceuticals
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Pfizer
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Bristol-Myers Squibb Company
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 GlaxoSmithKline plc
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Amgen Inc.
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Fabry Disease Therapeutic Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Teva pharmaceutical Industries Ltd.
3.12 Merc & Co.
3.13 AbbVie Inc.
3.14 Takeda Pharmaceutical Co. Ltd.
3.15 Green Cross Corp.

4 GLOBAL FABRY DISEASE THERAPEUTIC MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Fabry Disease Therapeutic Market Size by Type (2012-2017)
4.2 Global Fabry Disease Therapeutic Market Size by Application (2012-2017)
4.3 Potential Application of Fabry Disease Therapeutic in Future
4.4 Top Consumer/End Users of Fabry Disease Therapeutic

5 UNITED STATES FABRY DISEASE THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Fabry Disease Therapeutic Market Size (2012-2017)
5.2 United States Fabry Disease Therapeutic Market Size and Market Share by Players (2016 and 2017)

6 EU FABRY DISEASE THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Fabry Disease Therapeutic Market Size (2012-2017)
6.2 EU Fabry Disease Therapeutic Market Size and Market Share by Players (2016 and 2017)

7 JAPAN FABRY DISEASE THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Fabry Disease Therapeutic Market Size (2012-2017)
7.2 Japan Fabry Disease Therapeutic Market Size and Market Share by Players (2016 and 2017)

8 CHINA FABRY DISEASE THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

8.1 China Fabry Disease Therapeutic Market Size (2012-2017)
8.2 China Fabry Disease Therapeutic Market Size and Market Share by Players (2016 and 2017)

9 INDIA FABRY DISEASE THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

9.1 India Fabry Disease Therapeutic Market Size (2012-2017)
9.2 India Fabry Disease Therapeutic Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA FABRY DISEASE THERAPEUTIC DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Fabry Disease Therapeutic Market Size (2012-2017)
10.2 Southeast Asia Fabry Disease Therapeutic Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Fabry Disease Therapeutic Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Fabry Disease Therapeutic Revenue and Growth Rate (2017-2022)
  11.1.2 EU Fabry Disease Therapeutic Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Fabry Disease Therapeutic Revenue and Growth Rate (2017-2022)
  11.1.4 China Fabry Disease Therapeutic Revenue and Growth Rate (2017-2022)
  11.1.5 India Fabry Disease Therapeutic Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Fabry Disease Therapeutic Revenue and Growth Rate (2017-2022)
11.2 Global Fabry Disease Therapeutic Market Size (Value) by Type (2017-2022)
11.3 Global Fabry Disease Therapeutic Market Size by Application (2017-2022)

12 FABRY DISEASE THERAPEUTIC MARKET DYNAMICS

12.1 Fabry Disease Therapeutic Market Opportunities
12.2 Fabry Disease Therapeutic Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Fabry Disease Therapeutic Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Fabry Disease Therapeutic Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Fabry Disease Therapeutic Product Scope
Figure Global Fabry Disease Therapeutic Market Size (Million USD) (2012-2017)
Table Global Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Fabry Disease Therapeutic Market Share by Regions in 2016
Figure United States Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Fabry Disease Therapeutic Market Share by Type in 2016
Figure Enzyme Replacement Therapy Market Size (Million USD) and Growth Rate (2012-2017)
Figure Alternative therapies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Fabry Disease Therapeutic Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Fabry Disease Therapeutic Market Size (Million USD) by Players (2016 and 2017)
Figure Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure Fabry Disease Therapeutic Market Size Share by Players in 2017
Table Amicus therapeutics Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Amicus therapeutics (2012-2017)
Figure Amicus therapeutics Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Shire Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Shire (2012-2017)
Figure Shire Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Genzyme-Sanofi Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Genzyme-Sanofi (2012-2017)
Figure Genzyme-Sanofi Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Protalix Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Protalix (2012-2017)
Figure Protalix Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Sanofi-Aventis LLC Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Sanofi-Aventis LLC (2012-2017)
Figure Sanofi-Aventis LLC Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Novartis Pharmaceuticals Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Novartis Pharmaceuticals (2012-2017)
Figure Novartis Pharmaceuticals Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Company Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table GlaxoSmithKline plc Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of GlaxoSmithKline plc (2012-2017)
Figure GlaxoSmithKline plc Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Amgen Inc. Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Amgen Inc. (2012-2017)
Figure Amgen Inc. Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Teva pharmaceutical Industries Ltd. Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Teva pharmaceutical Industries Ltd. (2012-2017)
Figure Teva pharmaceutical Industries Ltd. Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Merc & Co. Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Merc & Co. (2012-2017)
Figure Merc & Co. Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table AbbVie Inc. Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of AbbVie Inc. (2012-2017)
Figure AbbVie Inc. Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Takeda Pharmaceutical Co. Ltd. Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Takeda Pharmaceutical Co. Ltd. (2012-2017)
Figure Takeda Pharmaceutical Co. Ltd. Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Green Cross Corp. Basic Information List
Table Fabry Disease Therapeutic Business Revenue (Million USD) of Green Cross Corp. (2012-2017)
Figure Green Cross Corp. Fabry Disease Therapeutic Business Revenue Market Share in 2016
Table Global Fabry Disease Therapeutic Market Size (Million USD) by Type (2012-2017)
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2012
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2013
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2014
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2015
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2016
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2017
Table Global Fabry Disease Therapeutic Market Size (Million USD) by Application (2012-2017)
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2012
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2013
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2014
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2015
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2016
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Fabry Disease Therapeutic
Figure United States Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Fabry Disease Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure United States Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure United States Fabry Disease Therapeutic Market Size Share by Players in 2017
Figure EU Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Fabry Disease Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure EU Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure EU Fabry Disease Therapeutic Market Size Share by Players in 2017
Figure Japan Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Fabry Disease Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure Japan Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure Japan Fabry Disease Therapeutic Market Size Share by Players in 2017
Figure China Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Fabry Disease Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure China Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure China Fabry Disease Therapeutic Market Size Share by Players in 2017
Figure India Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Fabry Disease Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure India Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure India Fabry Disease Therapeutic Market Size Share by Players in 2017
Figure Southeast Asia Fabry Disease Therapeutic Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Fabry Disease Therapeutic Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Fabry Disease Therapeutic Market Size Share by Players in 2016
Figure Southeast Asia Fabry Disease Therapeutic Market Size Share by Players in 2017
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Regions (2017-2022)
Table Global Fabry Disease Therapeutic Market Size (Million USD) by Regions (2017-2022)
Figure Global Fabry Disease Therapeutic Market Size Share by Regions in 2017
Figure Global Fabry Disease Therapeutic Market Size Share by Regions in 2022
Figure United States Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Fabry Disease Therapeutic Market Size (Million USD) by Type (2017-2022)
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2017
Figure Global Fabry Disease Therapeutic Market Size Share by Type in 2022
Table Global Fabry Disease Therapeutic Market Size (Million USD) by Application (2017-2022)
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2017
Figure Global Fabry Disease Therapeutic Market Size (Million USD) by Application in 2022